• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: a longitudinal study.

作者信息

De Luca Andrea, de Gaetano Donati Katleen, Cozzi-Lepri Alessandro, Colafigli Manuela, De Curtis Amalia, Capobianchi Maria Rosaria, Antinori Andrea, Giacometti Andrea, Magnani Giacomo, Vullo Vincenzo, Cauda Roberto, Iacoviello Licia, d'Arminio Monforte Antonella

出版信息

J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):e98-101. doi: 10.1097/QAI.0b013e318259875b.

DOI:10.1097/QAI.0b013e318259875b
PMID:22728753
Abstract
摘要

相似文献

1
Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: a longitudinal study.接受抑制性抗逆转录病毒治疗的HIV-1感染患者中阿巴卡韦暴露与心血管疾病生物标志物的关系：一项纵向研究。
J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):e98-101. doi: 10.1097/QAI.0b013e318259875b.
2
Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir.开始使用阿巴卡韦或替诺福韦进行抗逆转录病毒治疗的患者中炎症和促血栓形成生物标志物的早期变化。
BMC Infect Dis. 2011 Feb 4;11:40. doi: 10.1186/1471-2334-11-40.
3
Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy.在接受联合抗逆转录病毒治疗的 HIV-1 感染者中，转换用阿巴卡韦后心血管风险生物标志物的变化。
HIV Med. 2009 Nov;10(10):627-33. doi: 10.1111/j.1468-1293.2009.00733.x.
4
Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.炎症生物标志物与阿巴卡韦在妇女艾滋病研究机构间研究和多中心艾滋病队列研究中的应用。
AIDS. 2010 Jul 17;24(11):1657-65. doi: 10.1097/QAD.0b013e3283389dfa.
5
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction.基于阿巴卡韦的治疗不会影响与心血管功能障碍相关的生物学机制。
AIDS. 2010 Jan 28;24(3):F1-9. doi: 10.1097/QAD.0b013e32833562c5.
6
Effect of abacavir on acute changes in biomarkers associated with cardiovascular dysfunction.阿巴卡韦对与心血管功能障碍相关生物标志物急性变化的影响。
Antivir Ther. 2012;17(4):755-61. doi: 10.3851/IMP2020. Epub 2011 Dec 16.
7
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz.开始接受阿巴卡韦-拉米夫定或替诺福韦-恩曲他滨加依非韦伦治疗的初治HIV感染患者炎症和内皮激活血清标志物的变化
Curr HIV Res. 2016;14(1):61-70. doi: 10.2174/1570162x1401151102143222.
8
Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject.
AIDS. 2018 Jul 31;32(12):1727-1729. doi: 10.1097/QAD.0000000000001890.
9
Association between abacavir exposure and increased risk for cardiovascular disease in patients with human immunodeficiency virus.阿巴卡韦暴露与人类免疫缺陷病毒患者心血管疾病风险增加之间的关联。
Pharmacotherapy. 2010 Oct;30(10):1072-83. doi: 10.1592/phco.30.10.1072.
10
Abacavir and increased risk of myocardial infarction.阿巴卡韦与心肌梗死风险增加
Lancet. 2008 Sep 6;372(9641):803; author reply 804-5. doi: 10.1016/S0140-6736(08)61330-6.

引用本文的文献

1
Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: A systematic review and meta-analyses of results from 17 epidemiologic studies.与 HIV 感染者接触阿巴卡韦相关的心血管疾病风险：来自 17 项流行病学研究结果的系统评价和荟萃分析。
Int J Antimicrob Agents. 2018 Nov;52(5):541-553. doi: 10.1016/j.ijantimicag.2018.07.010. Epub 2018 Jul 21.
2
Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study.美国接受抗逆转录病毒治疗的艾滋病毒感染者中，当前、近期及累积接触阿巴卡韦导致心血管事件的风险：一项队列研究。
BMC Infect Dis. 2017 Oct 27;17(1):708. doi: 10.1186/s12879-017-2808-8.
3
Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function.在肾功能正常的患者中，从替诺福韦/恩曲他滨加阿扎那韦/利托那韦（ATV/r）转换为阿巴卡韦/拉米夫定加ATV/r后，对估计肾小球滤过率、胆固醇和甘油三酯进行评估的探索性分析。
Open AIDS J. 2016 Jul 15;10:136-43. doi: 10.2174/1874613601610010136. eCollection 2016.
4
Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration.对于感染HIV的个体，使用阿巴卡韦与心肌梗死风险之间是否仍存在关联？一项队列合作研究。
BMC Med. 2016 Mar 31;14:61. doi: 10.1186/s12916-016-0588-4.
5
Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected men.脂联素和白细胞介素-6，而非脂肪组织，与感染HIV的男性较差的神经认知功能有关。
Antivir Ther. 2015;20(2):235-44. doi: 10.3851/IMP2952. Epub 2015 Mar 26.